Clarus’ Oral Testosterone’s Perceived Advantage Becomes Downfall At FDA Panel

Oral dosing is “double-edge sword” as unique concerns with Rextoro’s formulation leads to negative advisory committee vote for the testosterone replacement treatment despite panelists’ desire for an oral option.